Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5JM4

Crystal structure of 14-3-3zeta in complex with a cyclic peptide involving an adamantyl and a dicarboxy side chain

Summary for 5JM4
Entry DOI10.2210/pdb5jm4/pdb
Related4N7G 4N84
Descriptor14-3-3 protein zeta/delta, GLN-GLY-MKD-ANG-ASP-MKD-LEU-ASP-LEU-ALA-CLU, BENZOIC ACID, ... (4 entities in total)
Functional Keywordspeptidomimetic, ppi inhibitor, macrocycle, signaling protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains4
Total formula weight55687.07
Authors
Bier, D.,Krueger, D.,Glas, A.,Wallraven, K.,Ottmann, C.,Hennig, S.,Grossmann, T. (deposition date: 2016-04-28, release date: 2017-05-10, Last modification date: 2024-01-10)
Primary citationKruger, D.M.,Glas, A.,Bier, D.,Pospiech, N.,Wallraven, K.,Dietrich, L.,Ottmann, C.,Koch, O.,Hennig, S.,Grossmann, T.N.
Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein-Protein Interactions.
J. Med. Chem., 60:8982-8988, 2017
Cited by
PubMed Abstract: Macrocyclic peptides can interfere with challenging biomolecular targets including protein-protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle. We report a virtual screen based on molecular docking that allows the affinity maturation of macrocyclic peptides taking non-natural amino acids into consideration. These macrocycles bear large and flexible substituents that usually complicate the use of docking approaches. A virtual library containing more than 1400 structures was screened against the target focusing on docking poses with the core structure resembling a known bioactive conformation. Based on this screen, a macrocyclic peptide 22 involving two non-natural amino acids was evolved showing increased target affinity and biological activity. Predicted binding modes were verified by X-ray crystallography. The presented workflow allows the screening of large macrocyclic peptides with diverse modifications thereby expanding the accessible chemical space and reducing synthetic efforts.
PubMed: 29028171
DOI: 10.1021/acs.jmedchem.7b01221
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.34 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon